UNSPSC 51152023: Dantrolene

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F64QU97QCR. European Medicines Agency schedules Dantrolene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06903MIG. Dantrolene generally arises in the molecular formula C14H10N4O5.

UNSPSC 51152023 Dantrolene is a Commodity code that in practice covers pharmaceutical products procured by state and local health agencies, though the single recent opportunity in the dataset shows a mismatch between the code's nominal scope and actual purchasing activity. Seminole County, Florida tagged its procurement under this code while soliciting Naloxone and Safe Drug Deactivation Systems—products outside dantrolene's pharmaceutical classification. The opportunity itself is concrete: Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2026. Vendors must include shipping and delivery costs in their bids, meet E-Verify and drug-free workplace requirements, and maintain workers' compensation and commercial general liability insurance. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination with or without cause. FEMA funding introduces compliance obligations under the Clean Air Act and Federal Water Pollution Control Act, with contractors subject to audits and record inspections.

The code shows limited recent activity in the dataset and insufficient information to characterize issuing-body concentration or geographic spread beyond the single Seminole County, Florida opportunity. If dantrolene procurement occurs under this code in other jurisdictions, the source does not capture it. Firms pursuing this code should treat the Seminole County procurement as an outlier—tagged under the wrong UNSPSC classification—and validate whether state and local health procurement offices actually use 51152023 for pharmaceutical buys or whether the category sits largely dormant in active state and local contracting.